Objectives: During proportional assist ventilation with load-adjustable gain factors, peak respiratory muscle pressure can be estimated from the peak airway pressure and the percentage of assistance (gain). Adjusting the gain can, therefore, target a given level of respiratory effort. This study assessed the clinical feasibility of titrating proportional assist ventilation with load-adjustable gain factors with the goal of targeting a predefined range of respiratory effort. Design: Prospective, multicenter, clinical observational study. Settings: Intensive care departments at five university hospitals. Patients: Patients were included after meeting simple criteria for assisted mechanical ventilation. Interventions: Patients were ventilated in proportional assist ventilation with load-adjustable gain factors. The peak respiratory muscle pressure, estimated in cm H 2 O as (peak airway pressure -positive end-expiratory pressure) × [(100 -gain)/gain], was calculated from a grid at the bedside. The gain adjustment algorithm was defined to target a peak respiratory muscle pressure between 5 and 10 cm H 2 O. Additional recommendations were available in case of hypoventilation or hyperventilation. Results: Fifty-three patients were enrolled. Median time spent under proportional assist ventilation with load-adjustable gain factors was 3 days (interquartile range, 1-5). Gain was adjusted 1.0 (0.7-1.8) times per day, according to the peak respiratory muscle pressure target range in 91% of cases and because of hypoventilation or hyperventilation in 9%. Thirty-four patients were ventilated with proportional assist ventilation with load-adjustable gain factors until extubation, which was successful in 32. Eighteen patients required volume assist-controlled reventilation because of clinical worsening and need for continuous sedation. One patient was intolerant to proportional assist ventilation with load-adjustable gain factors. Conclusions: This first study assessing the clinical feasibility of titrating proportional assist ventilation with load-adjustable gain factors in an attempt to target a predefined range of effort showed that adjusting the level of assistance to maintain a predefined boundary of respiratory muscle pressure is feasible, simple, and often sufficient to ventilate patients until extubation. (Crit Care Med 2013;41:2125-2132 
O ne of the main goals of assisted mechanical ventilation is to decrease the patient's respiratory effort (1) while maintaining some respiratory muscle activity. This approach not only reduces dyspnea and signs of respiratory distress but may also prevent the rapid respiratory muscle atrophy observed during controlled mechanical ventilation (2) and the resulting ventilator-induced diaphragmatic dysfunction (3) (4) (5) (6) (7) . It also helps to reduce the deleterious effects of prolonged sedation (8, 9) . To reach such goals, however, the amount of assistance should theoretically be adjusted to target normal or reasonable levels of respiratory effort. Unfortunately, measures of respiratory effort are not available for routine bedside use, except during physiological studies. Adjusting ventilator settings during assisted modes is, thus, a clinical challenge, associated with hazards for the patient.
Proportional assist ventilation with load-adjustable gain factors (PAV+) is a ventilatory mode that delivers assistance in proportion to the instantaneous flow and volume, calculating the instantaneous pressure needed to overcome the elastic and resistive pressures. This is done by performing automated and repeated measurements of compliance and resistance of the respiratory system (10) (11) (12) . Thus, assistance is expressed as a percentage of the total pressure needed to inflate the chest. This percentage, called the gain, is adjusted by the clinician. Because of its unique working principles, PAV+ allows to estimate the pressure generated by the respiratory muscles. Such an estimate can easily be done at the bedside from the values of the gain and the driving inspiratory airway pressure. By adjusting the gain, one can obtain a known level of respiratory muscle effort. We, therefore, designed a simple algorithm to adjust the gain during PAV+ in order to target a reasonable and predefined range of respiratory muscle pressure.
The aim of this study was to assess whether such an algorithm could be implemented safely and effectively to ventilate patients with PAV+ from the start of assisted ventilation until ventilator withdrawal.
MATERIALS AND METHODS
An extensive description of the methods is provided in the supplemental data (Supplemental Digital Content 1, http:// links.lww.com/CCM/A649).
This was a prospective, multicenter observational study involving five university hospitals, four in France (Angers, Créteil, Nice, Rouen) and one in Spain (Barcelona). The study was approved by the Ethics Committee of the Société de Réanimation de Langue Française (French Society of Intensive Care Medicine) and the Ethics Committee of the Sant Pau Hospital, Barcelona.
Patients
Patients were prospectively included while ventilated in assist control ventilation (ACV) as soon as the following criteria were met: ability to trigger every ventilator cycle, plateau pressure below 30 cm H 2 O with a tidal volume of 6-8 mL/kg of predicted body weight, positive end-expiratory pressure (PEEP) level ≤ 10 cm H 2 O, PaO 2 /Fio 2 > 150 or SaO 2 ≥ 90% with Fio 2 ≤ 50%, stable hemodynamic status with or without a moderate dose of vasopressor (epinephrine or norepinephrine ≤ 2 mg/ hr), body temperature between 36°C and 39°C, and Richmond Agitation Sedation Scale score ≥ −4 (13) . Patients were not included in case of age below 18 yr, pregnancy, "do not resuscitate" order or expected poor short-term prognosis, pneumothorax or chest tube with a suspicion of bronchopleural fistula, or prolonged cardiac arrest with poor neurological prognosis.
Measurements
Demographic, hemodynamic, and respiratory data, arterial blood gases and the Richmond Agitation Sedation Scale score were recorded at inclusion under ACV and daily under PAV+.
A laptop PC was connected to the ventilator, using a dedicated software that recorded the following parameters every minute over the whole duration of PAV+ ventilation: Fio 2 , PEEP, gain, peak airway pressure (P aw,Peak ), mean airway pressure (P aw,Mean ), respiratory rate (RR), expired tidal volume (Vte), and insufflation time (Ti).
Gain Adjustment Rules During PAV+
Patients were ventilated with PAV+ using a Puritan-Bennett 840 ventilator (Covidien, Galway, Ireland) until either extubation or the need to change the ventilatory mode.
The protocol to adjust the gain during PAV+ ventilation was designed to maintain the patient within a reasonable targeted range of respiratory effort, which we defined as a respiratory muscle pressure-time product (PTP mus ) between 50 and 150 cm H 2 O·s/min (1, 14) . As it was not feasible to directly calculate the PTP mus at the bedside, we used its major component as a surrogate: the peak muscle pressure of the respiratory muscles (P mus,Peak ). This pressure is the maximum swing made by the inspiratory muscles during inspiration, and it can be estimated breath by breath using the following equation:
where P aw,Peak is the peak airway pressure. A grid built from this equation was available at the bedside ( Fig. 1) , allowing the rapid estimate of the P mus,Peak . From the values of the gain, the PEEP, and the P aw,Peak , which all are available on the screen of the ventilator, the P mus,Peak can be immediately estimated.
By assuming that the muscle pressure (P mus ) waveform has a triangular shape with the end of the inspiratory effort at the P mus,Peak , the PTP mus , which represents the area under the P mus curve during the inspiratory time, could be estimated over a minute (in cm H 2 O·s/min) as follows ( Fig. 2) :
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where Ti is the inspiratory time and RR the respiratory rate.
From this estimation of the PTP mus , we considered that with usual values of Ti and RR (15) (16) (17) (18) , targeting a P mus,Peak between 5 and 10 cm H 2 O should allow the PTP mus to remain between 50 and 150 cm H 2 O·s/min. We then designed a simple algorithm, described in Fig. 3 , that primarily aimed at keeping the P mus,Peak between 5 and 10 cm H 2 O (P mus,Peak target range).
Briefly, we first defined some "standard P mus -settings" that only took into account this target range of P mus,Peak to adjust the gain during PAV+ and that had to be used first. We also defined "additional settings" that had to be used in case of hypoventilation This grid was available at the bedside and was used to adjust the gain in PAV+ (Fig. 3 ). The white area corresponds to the P mus,Peak target range (5 cm H 2 O ≤ P mus,Peak ≤ 10 cm H 2 O).
or hyperventilation observed despite a P mus,Peak within the target range. Both the Fio 2 and the PEEP were set according to the standard practice in each participating center. Patients were assessed every 8 hrs, or more frequently if needed, to adjust the ventilator settings. The study was ended either after extubation or when there was a need to switch back to ACV. Criteria for switching back to ACV were as follows: the need to increase the gain above 85%, the Fio 2 above 70%, or the PEEP above 10 cm H 2 O, and the need for prolonged continuous sedation. Withdrawal from mechanical ventilation was based on daily screening followed by a weaning trial performed with 7 cm H 2 O pressure support ventilation and zero PEEP. PAV+ gain was not used as an indicator of weaning capacity. Except for the ventilator settings, medical management did not differ from routine care.
Data Analysis
Each gain adjustment was classified whether it was made according to the P mus -setting rules or additional setting rules.
The data recorded every minute in the laptops connected to the ventilators, especially the Ti, RR, P aw,Peak , gain, and PEEP, allowed to calculate the percentage of the time spent in each range of PTP mus (<50, between 50 and 150, >150 cm H 2 O·s/ min) from Equation 2.
Statistics
Statistical analyses were performed using the Statistical Package for the Social Sciences (version 16.0, Chicago, IL). Continuous data are expressed as the median (25th, 75th percentile). Comparisons between patients who were and were not extubated at the end of the PAV+ ventilation were made using a Mann-Whitney U test. Comparisons among paired variables were made using a Wilcoxon signed-rank test. A two-sided p-value of 0.05 or less was considered statistically significant.
RESULTS

Population
Fifty-three patients were included. Their main demographic and clinical characteristics at enrolment are reported in Table 1 . Their respiratory parameters under ACV before starting PAV+ and at PAV+ inclusion are shown in Table 2 . Technical problems precluded the use of the laptop PC for data acquisition in eight patients. Estimation of the respiratory muscles pressure (P mus )-time product (PTP mus ). By considering that the muscle pressure waveform had a triangular shape with the end of the inspiratory effort at the P mus,Peak , the PTP mus , which represents the area under the P mus curve during the inspiratory time, could be calculated over a minute ( Feasibility and Compliance With the Protocol In all but one patient, the protocol succeeded in maintaining the P mus,Peak within the target range. The total number of gain adjustments in the 53 patients amounted to 247 ( Table 3 ). The median number of gain adjustments per patient per day was 1.0 (0.7, 1.8). Among the 247 gain adjustments, the P mus -settings were used 225 times (91%) to target the P mus,Peak between 5 and 10 cm H 2 O; six of these adjustments (2%) deviated modestly from the protocol because they were made in steps of 5% rather than 10% as defined in the protocol. No other protocol deviation was recorded. Additional settings were used in 22 instances (9%) and concerned 12 patients (23%), representing 29% (17, 33) of the total adjustments that these 12 patients required. Reasons for using additional settings are reported in Table 3 .
PTP mus Range
Based on the analysis of the minute-by-minute recordings of the ventilatory data (n = 45), patients spent 79% (64, 85) of their time with a PTP mus between 50 and 150 cm H 2 O·s/ min, 3% (2, 8) with a PTP mus less than 50 cm H 2 O·s/min, and 15% (8, 25) with a PTP mus over 150 cm H 2 O·s/min. Table 4 shows the mean values of respiratory parameters recorded in 45 patients during PAV+ ventilation, as well as their minute-by-minute coefficient of variation. Concerning tidal volume, patients spent 27% (2, 43) of their time with a Vte less than 6 mL/kg, 57% (37, 69) with a Vte between 6 and 8 mL/kg, and 16% (3, 31) with a Vte higher than 8 mL/kg.
Respiratory Parameters Under PAV+
Patient Outcome
Patients spent 3 days (1, 5) under PAV+. Thirty-four patients were extubated, and two of them required reintubation within the next 48 hrs (6%). Sixteen had failed the first weaning trial before extubation. The median gain was not significantly different in case of success and failure of the weaning trial: 48% (35, 59) and 50% (40, 60), respectively, p = 0.189. In 31 of these 34 patients ventilated with PAV+ until first extubation (91%), 100% of the gain adjustments had been made according to the P mus -settings. In the remaining 19 patients, ventilation with ACV was resumed. These latter patients had a higher SAPS II at inclusion (42 [37, 50] vs 34 [27, 41] ; p = 0.02) and had spent more days under ACV before inclusion (6 d [5, 9] vs 4 [2, 6] ; p = 0.01). All files were carefully analyzed to determine the reason for switching back to ACV. The main reasons for switching to ACV were clinical worsening requiring continuous sedation in 18 patients and the need to increase the gain to above 85% in one patient. This last patient had a metabolic acidosis and was eventually weaned successfully under pressure support ventilation.
DISCUSSION
This is the first study in which the level of assistance was individually adjusted to target each patient's respiratory effort. It is also the first report to include patients who were ventilated with PAV+ from the start of partial ventilatory support until the moment of extubation.
Targeting the Patient's Respiratory Effort to Adjust the Gain
As unloading the respiratory muscles is the first aim of assisted mechanical ventilation (1), adjusting the level of assistance to target a predefined range of patient's respiratory effort seems highly desirable. However, the direct measure of the respiratory muscle pressure is not possible in clinical practice. Using common modes of assisted mechanical ventilation, such as ACV or pressure support ventilation (PSV) (19) , such a direct measure would require measurement of the esophageal pressure and calculation of the chest wall compliance (14) . Furthermore, any modification in the level of assistance during PSV alters both the respiratory effort (20) and the respiratory pattern (Vte, Ti, RR) (16), making it difficult to optimize patient-ventilator interactions (21) .
With proportional assist ventilation, the level of gain minimally influences tidal volume (16) and keeps insufflation time very close to the neural inspiratory time (22) . With this mode, patients freely maintain their own respiratory pattern and minute ventilation. Modifying the gain, therefore, mainly alters the respiratory effort. Consequently, setting the gain in PAV+ to target a predefined reasonable range of respiratory effort makes sense in terms of patient-ventilator interactions and physiological effects. Unlike ACV and PSV, PAV+ uses the equation of motion of the respiratory system as a working principle (23) . Peak pressure performed by the respiratory muscles can, therefore, be calculated at the bedside (P mus,Peak ) (24). Kondili et al (25) showed that during PAV+, estimating muscle pressure from flow and airway pressure signals and respiratory mechanics using the equation of motion was accurate.
In this study, we designed an algorithm aiming to maintain the P mus,Peak between 5 and 10 cm H 2 O because we estimated that this should allow the PTP mus to remain between 50 and 150 cm H 2 O·s/min. Jubran et al (14) showed that-assuming dynamic hyperinflation was absent-the PTP of the respiratory muscles was 141 ± 21 cm H 2 O·s/min at the beginning and 180 ± 22 cm H 2 O·s/min at the end of a successful weaning trial with a T-tube. It has also been reported that in difficult to wean patients, a weaning trial made using a T-tube required more respiratory effort than a trial using PSV with a pressure level at 7 cm H 2 O and no PEEP (26) . In contrast, a PTP mus less than 40 cm H 2 O·s/min is considered by some authors as excessive muscle unloading, raising fears about muscle injury (1) . We, therefore, hypothesized that a PTP mus between 50 and 150 cm H 2 O·s/ min should represent an acceptable and reasonable range of respiratory effort during assisted mechanical ventilation for most patients. Although this range is reasonable, it may not suit some subgroups of patients who have a different basal work of breathing and should be refined by further research. Furthermore, the optimal target effort may vary from patient to patient, even within our target range. Our algorithm allowed the PTP mus to remain within the target range for 79% (64, 85) of the time and required only 1.0 (0.7, 1.8) adjustment of the gain per day. For comparison, Dojat et al (27) reported that adjusting pressure support levels 1 ± 2 times per day maintained patients in a predefined zone of respiratory comfort for 66% ± 23% of the time . In the same study, a computer-driven system to automatically adjust the pressure support level kept the patients within the comfort zone 93% ± 8% of the time, and assistance was adjusted 56 ± 40 times per day (27) . Taking these findings into account, we contend that our algorithm is simple and should be easy to implement in other ICUs.
PAV+ Ventilation in Clinical Practice
Using a target range of P mus,Peak to adjust the gain, we have shown that it is feasible to ventilate patients with PAV+ throughout the duration of partial ventilatory support, without any significant adverse event. In a randomized clinical study, Xirouchaki et al (28) reported the feasibility of using PAV+ compared with PSV for 48 hours. At the end of these 48 hours, the failure rate (i.e., the need to switch to controlled modes) was significantly lower in patients ventilated with PAV+ (11%) than in patients ventilated with PSV (22%).
Our study design did not allow comparison with another ventilatory mode or with other approaches using PAV+, such as gradually decreasing the proportion of ventilatory assistance. Although our algorithm is feasible, comparative studies with routine practice are needed. It is important to note that in accordance with standard practice (29) , weaning trials were performed in our study regardless of the level of assistance. The gain at the time of extubation ranged from 25% to 75%, Figure 3 and Patients section for definitions. and differences between weaning trial successes and failures were not significant. Eighteen patients needed to be switched back to ACV due to clinical worsening, and continuous sedation was required. This proportion is consistent with recent multicenter studies in the field of weaning and conducted using PSV (30, 31) .
One patient in our study did not tolerate the PAV+ mode and was switched to ACV. This patient had metabolic acidosis and his P mus,Peak remained above 10 cm H 2 O even though the gain was increased above 85% during PAV+. This clinical scenario raises some questions about how to select the patients who could benefit from PAV+. Because the assistance delivered during PAV+ is in proportion to the patient's respiratory effort, patients with a high respiratory drive not related to the load per se (e.g., patients with metabolic acidosis or central nervous system diseases) may not be good candidates for PAV+, especially if the assistance is adjusted according to the respiratory effort. Although overdistension has not been reported with PAV+-even at high levels of assistance (16, 28 )-clinicians should be aware that PAV+ may amplify an abnormal respiratory drive that is not related to the load per se.
Limitations
Our calculation of the P mus,Peak did not take into account the possible presence of an intrinsic PEEP (PEEPi). The value of the P mus,Peak could, therefore, have been underestimated in some patients. However, because tidal volume is chosen by the patient on a breath-by-breath basis (23) and the insufflation time is close to the neural inspiratory time (23, 32) whatever the level of assistance (16) , the risk of significant dynamic hyperinflation is low in PAV+ (22) . Furthermore, Appendini et al (15) showed that adding continuous positive airway pressure during proportional assist ventilation dramatically reduced the level of PEEPi in chronic obstructive pulmonary disease (COPD) patients with a high basal level of PEEPi. In our study, only three patients were intubated because of an acute exacerbation of a COPD. Furthermore, because we always used some level of PEEP in all patients, we think that PEEPi, even if present in some patients, would not have reached a level to substantially influence the results in a clinically significant manner. On the other hand, our results cannot be generalized to patients suspected to have a high basal level of PEEPi. Although we had a low proportion of patients ventilated for an acute exacerbation of COPD, it should be noted that this low proportion is consistent with the most recent international studies on the epidemiology of mechanical ventilation (19) . Without additional data, however, our algorithm should be used cautiously in these patients. Finally, we calculated the PTP mus by assuming a triangular shape of the muscle pressure trajectory over time (Equation 2). Direct measurement of the PTP mus using a double-balloon catheter would have yielded a more robust validation of our results, but measuring P mus,Peak and PTPmus in a clinical study would not have been feasible. Because previous physiological studies (24, 25) demonstrated a good correlation between the P mus calculated from PAV variables and the P mus measured with an esophageal catheter, we decided to rely on these data to build our clinical algorithm.
CONCLUSIONS
This study shows that setting PAV+ to achieve a predefined target range of reasonable respiratory effort is feasible, simple, and often sufficient to ventilate patients safely until ventilator withdrawal and extubation. Further studies are needed to investigate whether such an approach could provide benefits beyond current practice. 
